Monday, February 7, 2011
Novo's Soerensen Doesn't Plan to Diverge Beyond Diabetes
Feb. 2 (Bloomberg) -- Lars Rebien Soerensen, chief executive officer of Novo Nordisk AS, discusses business strategy for the worlds biggest insulin maker. Soerensen speaks with Shannon Pettypiece on Bloomberg Televisions "InsideTrack." (Source:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment